Going from 2.5mg to 5mg Mounjaro: what actually happens at your first dose increase

Four weeks in, and the 5mg pen is sitting in your fridge

Picture the moment: you have just finished your fourth 2.5mg injection, your repeat order has arrived, and the new pen in the fridge is labelled 5mg. That jump can feel bigger than it sounds. It helps to know what the prescribing schedule is actually designed to do.

The licensed titration for Mounjaro begins at 2.5mg because tirzepatide's dual action on GIP and GLP-1 receptors is powerful, and starting lower gives your gut time to adapt. Four weeks at 2.5mg is a settling-in period, not a therapeutic plateau. The NHS page on tirzepatide describes the dose escalation clearly: 2.5mg is an introductory dose and 5mg is where treatment begins.

That distinction matters practically. Many people notice relatively little change in appetite or weight during the first month. That is normal. The 5mg dose is when most patients begin to feel a meaningful reduction in hunger, earlier fullness and, over subsequent weeks, movement on the scales. Going from 2.5 to 5mg Mounjaro is not a dramatic leap, it is the point the medicine is designed to reach. You can read more about what to expect at 5mg Mounjaro if you want a fuller picture of that dose before you take it.

If your next pen is due around a bank holiday or a busy patch at work, order it a day or two earlier than usual, the same-day dispatch and next-working-day delivery promise only applies to working days, and a Monday or Tuesday order after a holiday weekend is common sense.

What tends to change, and what might catch you off guard

After going up to 5mg, the most common experience is a stepped-up version of any side effects you noticed at 2.5mg. Nausea is the one patients mention most. It tends to peak in the first two or three days after the injection and then ease. Digestive changes (slower bowel movements, or occasionally looser stools) are also frequently reported, as are mild fatigue and reduced appetite that can feel more pronounced than before.

This is not a sign something has gone wrong. The side effects when moving from 2.5 to 5mg Mounjaro follow a broadly predictable pattern: a short adjustment window, then gradual settling. The pattern tends to repeat at each subsequent dose increase, which is worth knowing before you get there.

A few practical things help during the transition. Eating smaller portions (something you may already be doing naturally because appetite has already shifted) reduces nausea significantly. Cold or room-temperature food tends to be easier than hot meals for some people. Staying well hydrated matters more than usual, because GLP-1 medicines slow gastric emptying and can make dehydration feel worse if you are also eating less. Alcohol is worth moderating. None of this replaces your prescriber's advice and the Patient Information Leaflet that comes with your pen, which covers the full picture.

The MHRA issued a Drug Safety Update in January 2026 drawing attention to acute pancreatitis as a known but uncommon risk with GLP-1 medicines. Severe stomach pain that radiates towards the back and does not settle warrants urgent medical attention, not a wait-and-see. For a broader look at managing side effects at this dose, the guide to going up to 5mg Mounjaro covers practical strategies in more detail.

What if 5mg feels like too much?

Some people find the step up harder than they expected. Persistent nausea that is disrupting daily life, significant vomiting or a real inability to eat enough are signals to talk to your prescriber rather than push through. Staying at 2.5mg for a second four-week period before trying 5mg again is a legitimate clinical path, the titration schedule exists to guide most patients, not to bind every patient to a fixed timetable.

Similarly, if 5mg is well tolerated and you are wondering about the next step from 5 to 7.5mg, that decision belongs to your prescriber too. The evidence base for tirzepatide, including the SURMOUNT-1 trial published in the New England Journal of Medicine, shows that greater average weight loss is associated with higher doses, but reaching those doses safely, over the right timeframe, matters as much as reaching them at all.

If you are currently on treatment and finding the dose change difficult, our prescribers at the nume clinical team review repeat orders before every dispatch, not as a formality, but to check exactly this kind of thing. Questions about reducing or pausing a Mounjaro dose are handled with the same care as increases. The right dose is the one that works for your body, not the highest one the schedule allows.

For a broader overview of how private Mounjaro treatment works in the UK, including what a full titration course looks like and how pricing is structured, the Mounjaro overview page is a good starting point. If you are weighing up the cost side, Eli Lilly's 2025 UK price change and what it means for private prescriptions is covered there too. When you are ready to talk through your specific situation with a prescriber, starting a free consultation is the next step.